425 related articles for article (PubMed ID: 32185589)
1. Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors.
Shibli F; Kitayama Y; Fass R
Curr Gastroenterol Rep; 2020 Mar; 22(4):16. PubMed ID: 32185589
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment of GERD: Where we are now, and where are we going?
Scarpignato C; Hongo M; Wu JCY; Lottrup C; Lazarescu A; Stein E; Hunt RH
Ann N Y Acad Sci; 2020 Dec; 1482(1):193-212. PubMed ID: 32935346
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological management of GERD: where does it stand now?
Hershcovici T; Fass R
Trends Pharmacol Sci; 2011 Apr; 32(4):258-64. PubMed ID: 21429600
[TBL] [Abstract][Full Text] [Related]
4. Potassium-competitive acid blockers and gastroesophageal reflux disease.
Leowattana W; Leowattana T
World J Gastroenterol; 2022 Jul; 28(28):3608-3619. PubMed ID: 36161043
[TBL] [Abstract][Full Text] [Related]
5. Management of Gastroesophageal Reflux Disease.
Gyawali CP; Fass R
Gastroenterology; 2018 Jan; 154(2):302-318. PubMed ID: 28827081
[TBL] [Abstract][Full Text] [Related]
6. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
Johnson DA; Levy BH
Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
[TBL] [Abstract][Full Text] [Related]
8. HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT.
Zaterka S; Marion SB; Roveda F; Perrotti MA; Chinzon D
Arq Gastroenterol; 2019 Aug; 56(2):202-208. PubMed ID: 31460587
[TBL] [Abstract][Full Text] [Related]
9. The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease.
Scarpignato C; Hunt RH
Curr Opin Gastroenterol; 2019 Jul; 35(4):344-355. PubMed ID: 31045597
[TBL] [Abstract][Full Text] [Related]
10. New and future drug development for gastroesophageal reflux disease.
Maradey-Romero C; Fass R
J Neurogastroenterol Motil; 2014 Jan; 20(1):6-16. PubMed ID: 24466441
[TBL] [Abstract][Full Text] [Related]
11. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.
Hershcovici T; Fass R
Drugs; 2011 Dec; 71(18):2381-9. PubMed ID: 22117130
[TBL] [Abstract][Full Text] [Related]
12. Current Trends in the Management of Gastroesophageal Reflux Disease.
Sandhu DS; Fass R
Gut Liver; 2018 Jan; 12(1):7-16. PubMed ID: 28427116
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
[TBL] [Abstract][Full Text] [Related]
14. Acid suppression therapy: where do we go from here?
Scarpignato C; Pelosini I; Di Mario F
Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
[TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
Tack J
Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
[TBL] [Abstract][Full Text] [Related]
17. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
Hershcovici T; Fass R
Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
[TBL] [Abstract][Full Text] [Related]
18. Management of gastroesophageal reflux disease: medications, surgery, or endoscopic therapy? (Current status and trends).
Zhi XT; Kavic SM; Park AE
J Long Term Eff Med Implants; 2005; 15(4):375-88. PubMed ID: 16022648
[TBL] [Abstract][Full Text] [Related]
19. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?
Tack J; Fass R
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():28-34. PubMed ID: 14725576
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends.
Kasugai K; Ogasawara N
Intern Med; 2024 Jan; 63(1):1-10. PubMed ID: 36927966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
